Search for: "People v. Levell (1988)" Results 281 - 300 of 461
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Nov 2013, 9:46 am by Jane Chong
Over the last month, on our New Republic: Security States newsfeed, we rolled out a series designed to explain why fairly allocating the costs of software deficiencies between software makers and users is so critical to addressing the growing problem of vulnerability-ridden code—and how such a regime will require questioning some of our deep-seated beliefs about the very nature of software security. [read post]
29 Aug 2013, 9:46 am by Terry Hart
One is the antenna goes to a house full of people, friends, alright, so it’s kind of public, it seems to me. [read post]
15 Aug 2013, 8:10 am
  That last point requires an unconventional course, such as "Elements," to be able to add value measured both by its contribution to a rigorous standard of substantive quality and a high level of relevance for the integrated program of study leading to a flexible but useful J.D. [read post]
5 Aug 2013, 11:00 am by Paul Rosenzweig
 As the Court held in Fisher v. [read post]
30 Jul 2013, 8:03 am by Maya Angenot
Morgentaler, [1988] 1 SCR 30, for instance. [read post]
19 Jun 2013, 3:00 am by Dianne Saxe
That principle is also recognized at the international level. [read post]
10 Jun 2013, 8:31 am by Soroush Seifi
  This branch of public lawyers have the opportunity for an extensive career in the criminal law and are afforded a great level of discretion in our liberal criminal justice system. [read post]
10 Jun 2013, 8:31 am by Soroush Seifi
  This branch of public lawyers have the opportunity for an extensive career in the criminal law and are afforded a great level of discretion in our liberal criminal justice system. [read post]
6 Jun 2013, 12:15 am
Also, Orphan Drug exclusivity only applies to rare diseases (affecting less than 200,000 people in the US and fewer than 5 people per 10,000 in the EU) [and is] shorter than average patent protection (12 years). [read post]
5 Jun 2013, 5:29 am by Schachtman
Med. 771 (1988); Joshua Muscat & Michael Huncharek, “Causation and disease: Biomedical science in toxic tort litigation,” 31 J. [read post]